Repare Therapeutics

$32.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.06%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RPTX and other stocks, options, and ETFs commission-free!

About RPTX

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

CEO
Lloyd M. Segal
Employees
102
Headquarters
Saint-Laurent, Québec
Founded
2016
Market Cap
1.21B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
153.69K
High Today
$33.01
Low Today
$31.07
Open Price
$32.11
Volume
90.22K
52 Week High
$46.44
52 Week Low
$21.45

RPTX Earnings

-$2.45
-$1.63
-$0.82
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

API
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure